Department of Orthopaedics, West China Hospital, West China School of Medicine, Sichuan University, No. 37, Wuhou Guoxue Road, 610041, Chengdu, Sichuan, P. R. China.
BMC Musculoskelet Disord. 2021 Nov 8;22(1):931. doi: 10.1186/s12891-021-04830-4.
The use of a tourniquet during high tibial osteotomy (HTO) is a routine procedure, but there is currently no research on the benefits and potential risks of tourniquet use during HTO. The aim of this study was to investigate the impact of tourniquet on perioperative blood loss, early functional recovery and complications in opening wedge HTO with modern tranexamic acid protocols.
This was a retrospective cohort study of patients who underwent unilateral opening wedge HTO between January 2019 and September 2020. All patients were divided into two groups according to whether a tourniquet was applied during HTO. Patients in both groups received the same surgical procedures, tranexamic acid protocols and other perioperative treatments. Preoperative baseline data, intraoperative data, early postoperative recovery and all complications during the 3-month follow-up were collected and compared between the two groups.
A total of 62 patients were enrolled in this study, including 32 in the tourniquet group and 30 in the non-tourniquet group. There was no significant difference in preoperative baseline data between the two groups (P > 0.05 in all). Intraoperative blood loss in the tourniquet group was significantly lower than that in the non-tourniquet group (80.22 ml versus 94.00 ml, P < 0.001), but there was no difference in total blood loss (187.39 ml versus 193.31 ml, P = 0.714). And no patient in either group required blood transfusion. In terms of early postoperative recovery, tourniquet use significantly increased pain scores and reduced knee range of motion on the first and second postoperative days, but there was no significant difference between the two groups at postoperative third day and third month. Furthermore, there was no significant difference between the two groups in terms of lower limb force line correction, length of stay, Knee Society Score or the incidence of complications during the 3-month follow-up (P > 0.05 in all).
In opening wedge HTO with modern tranexamic acid protocols, not using a tourniquet does not increase perioperative total blood loss or the risk of complications, but facilitates early postoperative recovery by reducing pain and increasing range of motion.
在胫骨高位截骨术(HTO)中使用止血带是常规操作,但目前尚无关于止血带在 HTO 中使用的益处和潜在风险的研究。本研究旨在探讨在现代氨甲环酸方案下,使用止血带对 HT0 围手术期失血、早期功能恢复和并发症的影响。
这是一项回顾性队列研究,纳入了 2019 年 1 月至 2020 年 9 月期间接受单侧 HT0 的患者。所有患者根据术中是否使用止血带分为两组。两组患者均接受相同的手术流程、氨甲环酸方案和其他围手术期治疗。收集并比较两组患者的术前基线数据、术中数据、早期术后恢复和 3 个月随访期间的所有并发症。
本研究共纳入 62 例患者,其中止血带组 32 例,非止血带组 30 例。两组患者术前基线数据无显著差异(P>0.05)。止血带组术中失血量明显低于非止血带组(80.22ml 比 94.00ml,P<0.001),但总失血量无差异(187.39ml 比 193.31ml,P=0.714)。两组均无患者需要输血。在早期术后恢复方面,止血带的使用显著增加了术后第 1、2 天的疼痛评分和膝关节活动度,但术后第 3 天和第 3 个月两组间无显著差异。此外,两组下肢力线校正、住院时间、膝关节协会评分或 3 个月随访期间并发症发生率均无显著差异(P>0.05)。
在现代氨甲环酸方案下的胫骨高位截骨术中,不使用止血带不会增加围手术期总失血量或并发症风险,但通过减少疼痛和增加活动度来促进术后早期恢复。